
51 - 200 employees
🧬 Biotechnology
💊 Pharmaceuticals
🔥 Funding within the last year
💰 $500M Post-IPO Debt - Celcuity on 2025-09
Biotechnology • Pharmaceuticals
Celcuity is a clinical-stage biotechnology company developing targeted therapies that comprehensively block the PI3K/AKT/mTOR (PAM) pathway to treat multiple solid tumors. Its lead product candidate, gedatolisib, is a potential first-in-class pan-PI3K and mTORC1/2 inhibitor in late-stage clinical development (including Phase 3 VIKTORIA trials) for HR+/HER2- advanced breast cancer and other indications such as prostate cancer. The company advances a focused pipeline of PAM pathway inhibitors, publishes clinical data, engages with investors and regulators, and is mission-driven to improve outcomes for cancer patients.
🕒 March 30
Improve your chances of getting an interview by checking your resume score before you apply.

51 - 200 employees
🧬 Biotechnology
💊 Pharmaceuticals
🔥 Funding within the last year
💰 $500M Post-IPO Debt - Celcuity on 2025-09
Biotechnology • Pharmaceuticals
Celcuity is a clinical-stage biotechnology company developing targeted therapies that comprehensively block the PI3K/AKT/mTOR (PAM) pathway to treat multiple solid tumors. Its lead product candidate, gedatolisib, is a potential first-in-class pan-PI3K and mTORC1/2 inhibitor in late-stage clinical development (including Phase 3 VIKTORIA trials) for HR+/HER2- advanced breast cancer and other indications such as prostate cancer. The company advances a focused pipeline of PAM pathway inhibitors, publishes clinical data, engages with investors and regulators, and is mission-driven to improve outcomes for cancer patients.
• Provide technical expertise and oversight of programming by CRO partners • Work as part of a multidisciplinary team, providing programming support for clinical trials • Coordinate and execute on preparation, execution, reporting and documentation of statistical programming activities • Design and develop SAS programs to execute statistical analysis and clinical trial reporting deliverables • Develop and perform appropriate quality control and validate clinical trials outputs • Establish collaborative partnerships with internal and external programmers, data managers, and clinical staff
• Minimum 8 to 12 years of industry experience (pharmaceuticals, biotechnology, or CRO) • Strong CRO oversight experience • Solid verbal and written communication skills • Demonstrated ability to speak up appropriately and ask necessary questions • Experience in clinical trials related to oncology for solid tumors • Experienced hands-on skill in programming with SAS is required • Good knowledge of statistics and oncology drug development process • Strong experience performing quality control of datasets (ADaM, SDTM, SEND) based on CDISC dataset specifications
• Annual performance incentive bonus • New hire equity package • Medical insurance • Dental insurance • Vision insurance • 401(k) match • Paid time off • Paid holidays
Apply Now🕒 March 29
10,000+ employees
Associate Director managing Investigator Initiated Trials for BeOne, ensuring compliance with FDA regulations and supporting project management and review processes across multiple sites.
🕒 March 28
Strategic partner and trusted advisor to healthcare clients ensuring successful coding solutions. Driving operational improvements and clinical workflows for better care delivery in healthcare organizations.
🕒 March 28
Director of Implementation Success leading healthcare coding solutions for US clients. Overseeing implementation, change management, and ensuring client satisfaction for IKS Health's coding services.
🕒 March 28
Senior Executive Director leading Market Impact efforts for March of Dimes. Responsible for strategy, donor cultivation, and community partnerships in maternal and infant health.
🕒 March 28
Senior Director of Donor Development at March of Dimes focusing on donor relationships and mission impact in maternal and child health care. Leading staff management and fundraising initiatives with strong leadership skills.